| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | Adalimumab | 3336 | |
| PURCH | PURCH_ATC(L04AB01) | Etanercept | 2396 | |
| PURCH | PURCH_ATC(L04AB06) | Golimumab | 1205 | |
| PURCH | PURCH_ATC(L04AB05) | Certolizumab pegol | 607 | |
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 548 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 520 | |
| PURCH | PURCH_ATC(L04AA24) | Abatacept | 491 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 346 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 44 | |
| PURCH | PURCH_ATC(L04AB02) | Infliximab | 24 |